Interleukin-7 (IL-7) therapy can reinvigorate T cell responses in chronic viral infection, and Pellegrini et al. (Cell, 2011) showed in the LCMV clone-13 model that this effect hinges on the downregulation of Socs3, an intracellular brake on cytokine signaling, in T cells. How IL-7 signaling actually lowers Socs3 expression — in particular whether it acts through PI3K–Akt-mediated inhibition of FoxO transcription factors reducing Socs3 transcription, as proposed in the source work, or through another transcriptional or post-transcriptional route — was left unresolved and, despite substantial follow-up literature on IL-7 therapy, SOCS3 biology, and FoxO factors in chronic infection, has not been directly dissected. The problem is to determine and causally validate this mechanism in T cells during chronic viral infection.

Background

Interleukin-7 (IL-7) is a cytokine secreted mainly by stromal cells of the thymus, bone marrow, and lymphoid organs that is required for T cell development and for the survival of naive and memory T cells; it signals through a receptor composed of IL-7Rα (CD127) and the common gamma-chain (γc), activating the JAK/STAT5, PI3K–Akt, and MAPK pathways inside the cell. SOCS3 (suppressor of cytokine signaling 3) is an inducible intracellular negative-feedback protein that binds and inhibits JAK kinases and promotes degradation of signaling components, thereby damping signaling particularly from IL-6-type (gp130) cytokines and granulocyte colony-stimulating factor (G-CSF). Lymphocytic choriomeningitis virus (LCMV) clone-13 is a widely used mouse model of chronic viral infection: mice infected with this strain remain persistently viremic because virus-specific T cells become dysfunctional, a state called T cell exhaustion. Pellegrini et al. (2011) treated clone-13-infected mice with IL-7 and found that IL-7 lowered the amount of Socs3 in T cells; the released cytokine signaling (dependent on endogenous IL-6) increased T cell numbers and effector function, enabled viral clearance, expanded naive T cell output from the thymus, and induced the tissue-protective cytokine IL-22 that prevented liver damage. Broad deletion of Socs3 in all hematopoietic cells, however, caused severe neutrophilia (an elevated neutrophil count) and early death in infected mice, indicating that systemic removal of this brake is dangerous and that the IL-7 route is the therapeutically interesting one. The source work proposed, but did not prove, that IL-7 represses Socs3 by activating the PI3K–Akt pathway: Akt, a kinase downstream of PI3K, phosphorylates FoxO transcription factors (a family that includes FoxO1 and FoxO3, active in the nucleus of quiescent cells), causing their retention in the cytoplasm and loss of their gene-regulatory activity; if FoxO factors normally help drive Socs3 transcription in exhausted T cells, IL-7-activated Akt would lower Socs3 expression. This causal chain (IL-7 → Akt → FoxO inactivation → reduced Socs3 transcription) has never been directly tested: no published study has mapped FoxO occupancy of the Socs3 locus in T cells under IL-7 signaling or performed the genetic epistasis (FoxO loss preserving or abolishing the IL-7 effect on Socs3). Related but distinct regulatory layers are known: N6-methyladenosine (m6A) mRNA methylation controls the stability of SOCS-family transcripts in T cells downstream of IL-7/STAT5, and SOCS3 itself is required for IL-7Rα re-expression after T cell activation, so Socs3 abundance in T cells is set by interacting transcriptional and post-transcriptional mechanisms whose relative role in the IL-7 effect seen in chronic infection is unknown.

Problem Statement

Determine the molecular mechanism by which IL-7 signaling lowers Socs3 expression in T cells during chronic viral infection — the step left unresolved by Pellegrini et al. (Cell, 2011), where IL-7 treatment of LCMV clone-13-infected mice repressed Socs3 in T cells and thereby unleashed IL-6-dependent cytokine signaling, T cell effector function, and viral clearance. Characterizing this mechanism includes establishing whether the repression is transcriptional (reduced Socs3 promoter activity or nascent transcription) or post-transcriptional (altered Socs3 mRNA stability), or a defined combination, and directly evaluating the source's proposed causal chain that IL-7-activated PI3K–Akt inhibits FoxO family transcription factors (FoxO1/FoxO3) that otherwise support Socs3 transcription in T cells — for example by measuring FoxO occupancy and activity at the Socs3 locus under IL-7 signaling and by genetic or pharmacological epistasis (combined perturbation of IL-7 signaling and FoxO, asking whether FoxO loss abrogates or preserves the IL-7 effect on Socs3) — against other transcriptional or post-transcriptional routes, causally validated in T cells in the chronic-infection setting.

References

  1. Pellegrini M, Calzascia T, Toe JG, Preston SP, Lin AE, Elford AR, Shahinian A, Lang PA, Lang KS, Morre M, Assouline B, Lahl K, Sparwasser T, Tedder TF, Paik JH, DePinho RA, Basta S, Ohashi PS, Mak TW. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 2011;144(4):601-613. DOI: 10.1016/j.cell.2011.01.011. https://doi.org/10.1016/j.cell.2011.01.011
  2. Parish IA, Kaech SM. IL-7 knocks the socs off chronic viral infection. Cell 2011;144(4):467-468. DOI: 10.1016/j.cell.2011.01.038. https://doi.org/10.1016/j.cell.2011.01.038
  3. Croker BA, Metcalf D, Robb L, Wei W, Mifsud S, DiRago L, Cluse LA, Sutherland KD, Hartley L, Williams E, Zhang JG, Hilton DJ, Nicola NA, Alexander WS, Roberts AW. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 2004;20(2):153-165. DOI: 10.1016/S1074-7613(04)00022-6. https://doi.org/10.1016/S1074-7613(04)00022-6
  4. Croker BA, Kiu H, Pellegrini M, Toe J, Preston S, Metcalf D, O'Donnell JA, Cengia LH, McArthur K, Nicola NA, Alexander WS, Roberts AW. IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3. Immunology and Cell Biology 2012;90(1):124-129. DOI: 10.1038/icb.2011.29. https://doi.org/10.1038/icb.2011.29
  5. Carow B, Rottenberg ME. SOCS3, a major regulator of infection and inflammation. Frontiers in Immunology 2014;5:58. DOI: 10.3389/fimmu.2014.00058. https://doi.org/10.3389/fimmu.2014.00058
  6. Sullivan JA, Kim EH, Plisch EH, Suresh M. FOXO3 regulates the CD8 T cell response to a chronic viral infection. Journal of Virology 2012;86(17):9025-9034. DOI: 10.1128/JVI.00942-12. https://doi.org/10.1128/JVI.00942-12
  7. Li HB, Tong J, Zhu S, Batista PJ, Duffy EE, Zhao J, Bailis W, Cao G, Kroehling L, Chen Y, Wang G, Broughton JP, Chen YG, Kluger Y, Simon MD, Chang HY, Yin Z, Flavell RA. m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways. Nature 2017;548(7667):338-342. DOI: 10.1038/nature23450. https://doi.org/10.1038/nature23450
  8. Hou H, Kang Y, Zeng Y, Li Y, Shang J. Interleukin-7 augments CD8+ T cells function and promotes viral clearance in chronic hepatitis C virus infection. Cytokine 2018;102:26-33. DOI: 10.1016/j.cyto.2017.12.014. https://doi.org/10.1016/j.cyto.2017.12.014
  9. Güler A, Lopez Venegas M, Adankwah E, Mayatepek E, Nausch N, Jacobsen M. Suppressor of cytokine signalling 3 is crucial for interleukin-7 receptor re-expression after T-cell activation and interleukin-7 dependent proliferation. European Journal of Immunology 2020;50(2):234-244. DOI: 10.1002/eji.201948302. https://doi.org/10.1002/eji.201948302
  10. Winer H, Rodrigues GOL, Hixon JA, Aiello FB, Hsu TC, Wachter BT, Li W, Durum SK. IL-7: Comprehensive review. Cytokine 2022;160:156049. DOI: 10.1016/j.cyto.2022.156049. https://doi.org/10.1016/j.cyto.2022.156049
  11. Levy Y, Lacabaratz C, Weiss L, Viard JP, Goujard C, Lelièvre JD, Boué F, Molina JM, Rouzioux C, Avettand-Fénoêl V, Croughs T, Beq S, Thiébaut R, Chêne G, Morre M, Delfraissy JF. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. Journal of Clinical Investigation 2009;119(4):997-1007. DOI: 10.1172/JCI38052. https://doi.org/10.1172/JCI38052
  12. Lee J, Niavi C, Ahn E, Kissick HT, Valanparambil RM, Nasti TH, McGuire DJ, Hua D, Obeng R, Wolfarth AA, Borgonia D, Ferrando-Martinez S, Choi D, Lee BH, Ahmed R. Expansion and mobilization of virus-specific stem-like CD8 T cells in chronic viral infection after treatment with a long-acting IL-7, NT-I7. Cell Reports 2026;45(4):117204. DOI: 10.1016/j.celrep.2026.117204. https://doi.org/10.1016/j.celrep.2026.117204